Ross Jenson, MD
Pain Medicine · Reno, NVNPI 1093190415
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $13,356 of the $19,151 with a category attached, or 69.7%. It is spread thinly across 35 manufacturers, the largest accounting for just 19.2%. Reporting peaked in 2019 at $3,467 and has fallen 66.9% since, to $1,149 in 2025. Among pain medicine clinicians in NV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 333 payments — averaging $57.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$4K
- Medtronic$3K
- Boston Scientific$3K
- Nevro Corp.$2K
- Relievant Medsystems, Inc.$1K
- Vertos Medical, Inc.$1K
- plus $3K from 29 others
Across 4 payments — averaging $42.54 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Saluda Medical Americas, Inc.$170
What the payments were for
- Travel & lodging$5,76830%
- Food & beverage$13,35670%
- Entertainment$260%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 96 | $3,676 |
| Medtronic(2 entities) | 47 | $3,476 |
| Boston Scientific | 24 | $3,199 |
| Nevro Corp. | 29 | $2,479 |
| Relievant Medsystems, Inc. | 16 | $1,499 |
| Vertos Medical, Inc. | 12 | $1,352 |
| Saluda Medical Americas, Inc. | 12 | $704 |
| AbbVie(2 entities) | 28 | $475 |
| Si-bone, Inc. | 6 | $285 |
| SPR Therapeutics, Inc | 6 | $253 |
| Stryker | 3 | $208 |
| Amgen | 7 | $185 |
| Nalu Medical, Inc. | 3 | $141 |
| Flowonix Medical Incorporated | 1 | $124 |
| Spinal Simplicity, LLC | 2 | $123 |
| Bioventus LLC | 1 | $115 |
| Vertex | 4 | $104 |
| Foundation Fusion Solutions, LLC | 2 | $94 |
| Teva Pharmaceuticals USA, Inc. | 5 | $85 |
| Avanos Medical | 1 | $64 |
| Pfizer | 3 | $60 |
| Biohaven Pharmaceuticals, Inc. | 3 | $58 |
| Collegium Pharmaceutical, Inc. | 3 | $58 |
| Lundbeck LLC | 3 | $47 |
| Biodelivery Sciences International, Inc. | 3 | $44 |
| Baudax Bio Inc. | 2 | $31 |
| Arbor Pharmaceuticals, Inc. | 2 | $31 |
| GRT US Holding, Inc. | 1 | $30 |
| Almatica Pharma LLC | 2 | $29 |
| Pacira Pharmaceuticals Incorporated | 1 | $27 |
| Tersera Therapeutics LLC | 1 | $26 |
| Upsher-smith Laboratories LLC | 1 | $26 |
| Impel Pharmaceuticals Inc. | 1 | $21 |
| USWM, LLC | 1 | $17 |
| Stratus Medical, LLC | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Intracept$4,591
- INTELLIS ADAPTIVESTIM$2,067
- SPECTRA WAVEWRITER$1,662
- Senza Spinal Cord Stimulation System$1,477
- mild Device Kit$987
- Proclaim IPG$857
- VANTA ADAPTIVESTIM$343
- Evoke SCS$319
- Proclaim Family of SCS IPGs$238
- WaveWriter Alpha Prime 16$170
- Senza$149
- SUPERION$149
- Omnia$149
- GENERAL - THERAPIES$146
- SYNCHROMEDII$135
- Proclaim DRG IPG$132
- SPRINT PNS System$131
- Prometra II$124
- Evoke$123
- KYPHON Balloon Kyphoplasty$118
How this compares
$19,151 in reported general payments places this provider in the 90th percentile of 101 pain medicine providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pregabalin | 165 | $4,828 |
| Gabapentin | 128 | $2,213 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 96 | $1,968 |
| Tizanidine Hcl | 120 | $1,767 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 46 | $1,288 |
| Naloxone Hcl | 16 | $1,154 |
| Oxycodone Hcl | 41 | $754 |
| Duloxetine Hcl | 24 | $694 |
| Methocarbamol | 39 | $525 |
| Cyclobenzaprine Hcl | 33 | $509 |
| Topiramate | 22 | $240 |
| Amitriptyline Hcl | 27 | $237 |
| Baclofen | 13 | $194 |
| Tramadol Hcl | 18 | $85 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Upsher-smith Laboratories LLCTopiramate | $26 | $24022 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 101 pain medicine providers in Nevada.
Other pain medicine in Reno
- Denis PattersonReno$816K
- Anwar MackReno$32K
- Jonathan BurnsReno$20K
- Michael GyorfiReno$17K
- Jacob BlakeReno$8K
- Jeffery MuirReno$6K
- Seneca StormReno$2K
- Rainer VogelHenderson$230K
- John DimuroPahrump$44K
- Kunal ParikhLas Vegas$26K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.